Pharmaceutical Collection (PHARMS)

This measure details the percentage of people aged 65 years and over who received the ‘triple whammy’ during the same 90-day period.  The term “triple whammy” refers to the concurrent use of an angiotensin converting enzyme (ACE) inhibitor or an angiotensin-II receptor blocker (ARB), with a diuretic and a non-steroidal anti-inflammatory drug (NSAID), including cyclo-oxygenase-2 (COX-2) inhibitors. 

This measure shows the percentage of people aged 65 years and over who were dispensed a benzodiazepine or zopiclone  and an antipsychotic in the same quarter during the calendar year. This measure cannot assess inappropriate use of these medicines, however, high rates of prescribing may indicate misuse or overuse. 

This measure shows the percentage of people aged 65 years and over who were dispensed a benzodiazepine or zopiclone during the calendar year. This measure cannot assess inappropriate use of these medicines, however, high rates of prescribing may indicate misuse or overuse. 

This measure shows the percentage of people aged 65 years and over who were dispensed five, six or seven unique long-term medicines. 

This measure shows the percentage of people aged 65 years and over who were dispensed eight, nine or ten unique long-term medicines. 

This measure shows the percentage of people aged 65 years and over who were dispensed five or more unique long-term medicines. 

This measure shows the percentage of people aged 65 years and over who were dispensed one or more antipsychotic medicines during the year. 

This measure shows the percentage of people aged 65 years and over who were dispensed 11 or more unique long-term medicines. 

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had tramadol dispensed to them by a community pharmacy, by year (2019 to 2023), ethnic group, age group, gender. 

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had dispensed codeine and dihydrocodeine to them by a community pharmacy, by year (2019 to 2023), ethnic group, age group, gender.